Hepatitis B Surface Antigen Declines and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype

(2011) Milan J Sonneveld et al.   ANTIVIRAL THERAPY

Six-year follow-up of hepatitis B surface antigen concentrations in tenofovir disoproxil fumarate treated HIV–HBV-coinfected patients

(2011) Vincent Thibault et al.   ANTIVIRAL THERAPY

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

(2011) Roeland Zoutendijk et al.   JOURNAL OF INFECTIOUS DISEASES

Hepatitis B surface antigen monitoring and management of chronic hepatitis B

(2011) M. J. Sonneveld et al.   JOURNAL OF VIRAL HEPATITIS

Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus

(2010) Theodora E.M.S. de Vries–Sluijs et al.   GASTROENTEROLOGY

Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis B

(2010) E. Jenny Heathcote et al.   GASTROENTEROLOGY

Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

(2010) Ting-Tsung Chang et al.   HEPATOLOGY

Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels

(2010) Vincent Rijckborst et al.   HEPATOLOGY

Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen decline

(2010) Milan J. Sonneveld et al.   HEPATOLOGY

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

(2010) Karsten Wursthorn et al.   HEPATOLOGY

Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers

(2010) Alexander J.V. Thompson et al.   HEPATOLOGY

Antiretroviral Treatment of Adult HIV Infection

(2010) Melanie A. Thompson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hepatitis B and long-term HIV outcomes in coinfected HAART recipients

(2009) Christopher J Hoffmann et al.   AIDS

Impact of Hepatitis B Virus Infection on the Progression of AIDS and Mortality in HIV‐Infected Individuals: A Cohort Study and Meta‐Analysis

(2009) Georgios K. Nikolopoulos et al.   CLINICAL INFECTIOUS DISEASES

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

(2008) Rami Moucari et al.   HEPATOLOGY

Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B

(2008) Maurizia Rossana Brunetto et al.   HEPATOLOGY

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B

(2008) Patrick Marcellin et al.   NEW ENGLAND JOURNAL OF MEDICINE